Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU TopicsInfectious Diseases

ICU · Infectious Diseases

Acute severe pneumonia: bacteraemia and metastatic infection

Also known as Bacteraemic pneumonia · Metastatic infection from pneumonia · Endocarditis from bacteraemia · Septic emboli

Bacteraemia complicates 10-25% of CAP cases and significantly increases mortality (2-3x). Most common organisms causing bacteraemia: S. pneumoniae (1, 60-70%), S. aureus (including MRSA — highest metastatic risk), Haemophilus influenzae. Bacteraemia enables metastatic seeding to distant sites: endocarditis (25% of S. aureus bacteraemia), meningitis, vertebral osteomyelitis, septic arthritis, psoas abscess, splenic abscess. Management: prolonged antibiotic course (14 days minimum for S. aureus bacteraemia), repeat blood cultures until negative, search for metastatic foci (echocardiogram, imaging), source control if identified. Persistent bacteraemia 72h despite appropriate antibiotics: search for deep focus.

low18 referencesUpdated 26 July 202615 min readVerification in progress

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • S. aureus bacteraemia: 25% have endocarditis — ALL need echocardiogram (TOE preferred)
  • Persistent bacteraemia >72h despite appropriate antibiotics: search for metastatic focus
  • S. aureus bacteraemia duration: minimum 14 days (4-6 weeks if endocarditis, osteomyelitis)
  • Bacteraemic CAP has 2-3x higher mortality than non-bacteraemic CAP
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • S. aureus bacteraemia: 25% have endocarditis — ALL need echocardiogram (TOE preferred)
  • Persistent bacteraemia >72h despite appropriate antibiotics: search for metastatic focus
  • S. aureus bacteraemia duration: minimum 14 days (4-6 weeks if endocarditis, osteomyelitis)
  • Bacteraemic CAP has 2-3x higher mortality than non-bacteraemic CAP
In one line

Bacteraemic CAP complicates 10 to 25 percent of community-acquired pneumonia (30 to 60 percent of ICU severe CAP) and carries 2 to 3 times the mortality of non-bacteraemic CAP. Streptococcus pneumoniae is the number-one organism (60 to 70 percent); Staphylococcus aureus is the number-one metastatic organism — 25 to 30 percent seed endocarditis, so every S. aureus bacteraemia gets a TOE. Treat as a systemic infection: prolonged IV therapy, repeat blood cultures to clearance, and an active hunt for metastatic foci. S. aureus needs a minimum of 14 days (4 to 6 weeks for endocarditis, 6 weeks for osteomyelitis), counted from the first negative culture.[1][2]

Meet the patient

A 64-year-old man with alcohol misuse and a post-trauma splenectomy five years ago — no vaccinations since — arrives with two days of rigors, pleuritic chest pain and confusion. He is in septic shock: MAP 55, lactate 5.0, right lower lobe consolidation, saturation 90 percent on room air. The blood cultures drawn in the emergency department flag positive at nine hours with gram-positive diplococci.[1]

The two questions that decide his next 72 hours are the two that define bacteraemic pneumonia: which organism, and where else has it gone? The organism sets the antibiotic and the duration; the metastatic hunt (endocarditis, meningitis, abscess) is what stops the preventable late death. Hold those two and the rest slots into place.[1]

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References18ShowHide
  1. [1]Niederman MS, Torres A. Severe community-acquired pneumonia. European respiratory review, 2022.PMID 36517046
  2. [2]Asgeirsson H, Thalme A, Weiland O Staphylococcus aureus bacteraemia and endocarditis - epidemiology and outcome: a review. Infectious diseases (London, England), 2018.PMID 29105519
  3. [3]Baddour LM, Wilson WR, Bayer AS, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation, 2015.PMID 26373316
  4. [4]Cahill TJ, Prendergast BD Infective endocarditis. Lancet (London, England), 2016.PMID 26341945
  5. [5]Fowler VG Jr, Sanders LL, Kong LK, et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999.PMID 10028079
  6. [6]Corey GR Staphylococcus aureus bloodstream infections: definitions and treatment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009.PMID 19374581
  7. [7]Luján M, Gallego M, Belmonte Y, et al. Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia. The European respiratory journal, 2010.PMID 20150202
  8. [8]Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive care medicine, 2021.PMID 34599691
  9. [9]Rybak MJ, Le J, Lodise TP, et al. Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020.PMID 32658968
  10. [10]Thorlacius-Ussing L, Sandholdt H, Nissen J, et al. Comparable Outcomes of Short-Course and Prolonged-Course Therapy in Selected Cases of Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Pooled Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021.PMID 33677515
  11. [11]Iversen K, Ihlemann N, Gill SU, et al. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis. The New England journal of medicine, 2019.PMID 30152252
  12. [12]Tahir F, Ahmed R, Safdar M, Haroon M. Post-splenectomy Sepsis: A Review of the Literature. Cureus, 2020.PMID 32195065
  13. [13]Pieralli F, Vannucchi V, Mancini A, et al. Procalcitonin Kinetics in the First 72 Hours Predicts 30-Day Mortality in Severely Ill Septic Patients Admitted to an Intermediate Care Unit. Journal of clinical medicine research, 2015.PMID 26251686
  14. [14]van de Beek D, Farrar JJ, de Gans J, et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. The Lancet. Neurology, 2010.PMID 20138011
  15. [15]Heriot GS, Cronin K, Tong SYC, et al. Criteria for Identifying Patients With Staphylococcus aureus Bacteremia Who Are at Low Risk of Endocarditis: A Systematic Review. Open forum infectious diseases, 2017.PMID 29308408
  16. [16]Kim SH, Jeon M, Jang S, Mun SJ. Factors for mortality in patients with persistent Staphylococcus aureus bacteremia: The importance of treatment response rather than bacteremia duration. Journal of microbiology, immunology, and infection, 2023.PMID 37580183
  17. [17]Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. American journal of respiratory and critical care medicine, 2019.PMID 31573350
  18. [18]Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011.PMID 21208910

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAcute severe community-acquired pneumonia: respiratory virus panelInfectious DiseasesNextFulminant Clostridioides difficile colitis: surgery, fidaxomicin, and bezlotoxumabInfectious diseases